US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INmune Bio Inc

1.82

0.0000

Post-market: 1.890.0700+3.85%19:59 EDT

Volume:321.48K

Turnover:588.32K

Market Cap:48.39M

PE:-0.72

High:1.89

Open:1.83

Low:1.79

Close:1.82

52wk High:11.64

52wk Low:1.71

Shares:26.59M

Float Shares:20.18M

Volume Ratio:1.04

T/O Rate:1.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5162

EPS(LYR):-2.1100

ROE:-168.34%

ROA:-55.08%

PB:1.68

PE(LYR):-0.86

Loading ...

Overview Company News Filings

BUZZ-INmune Bio rises as prostate cancer therapy meets trial goals

INmune Bio Announces Successful Completion of Phase I/II Trial for INKmune™ in Metastatic Castration-Resistant Prostate Cancer, Plans Phase 2b Trial

INmune Bio’s Care PC Trial of Inkmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment

THOMSON REUTERS

INmune Bio Inc - Inkmune Well Tolerated With Excellent Safety Profile

THOMSON REUTERS

INmune Bio Inc - Plans Phase 2B Trial for Less Severe Disease

THOMSON REUTERS

INmune Bio Inc. to Report Second Quarter 2025 Financial Results

INmune Bio Inc. Unveils Promising MINDFuL Trial Results for Alzheimer's Treatment XPro™ at AAIC 2025

INmune Bio Inc expected to post a loss of 38 cents a share - Earnings Preview

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

INmune Bio Is Maintained at Buy by Maxim Group

INmune Bio Shares Fall After Downgrade From BTIG Research

MT Newswires Live

INmune Bio Cut to Sector Underperform From Sector Outperform by Scotiabank

BTIG Research Downgrades INmune Bio to Neutral From Buy

MT Newswires Live

BUZZ-Scotiabank double downgrades rating on INmune Bio after Alzheimer's drug failure

INmune Bio Inc. Closes $19 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Raymond James Downgrades INmune Bio to Market Perform From Outperform; Shares Fall

MT Newswires Live

Top Premarket Decliners

MT Newswires Live

INmune Bio Inc. Seeks Breakthrough Therapy Designation for XPro™ Following Promising Phase 2 Alzheimer's Trial Results

INmune Bio Inc. Announces $19 Million Registered Direct Offering with Institutional Investors

24H | INmune Bio Soars 70% as It to Present Phase 2 Trial Data; BigBear.ai Jumps 5% After a 20% Rally in Prior Session

Tiger Newspress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INMB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INMB\",,,,,undefined,":{"symbol":"INMB","market":"US","secType":"STK","nameCN":"INmune Bio Inc","latestPrice":1.82,"timestamp":1761768000000,"preClose":1.82,"halted":0,"volume":321482,"hourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.82,"latestTime":"19:59 EDT","volume":6429,"amount":11852.1358,"timestamp":1761782366616},"delay":0,"floatShares":20177391,"shares":26585258,"eps":-2.516157,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-29 16:00:00 EDT","open":1.83,"high":1.89,"low":1.79,"amount":588317.7502314,"amplitude":0.054945,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.516157,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761811200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1549256400000,"exchange":"NASDAQ","adjPreClose":1.82,"preHourTrading":{"tag":"盘前","latestPrice":1.87,"preClose":1.82,"latestTime":"09:29 EDT","volume":2225,"amount":4090.2938175000004,"timestamp":1761744546749},"postHourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.82,"latestTime":"19:59 EDT","volume":6429,"amount":11852.1358,"timestamp":1761782366616},"volumeRatio":1.037946,"impliedVol":0.3168,"impliedVolPercentile":0.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INMB\",,,,,undefined,":{"symbol":"INMB","floatShares":20177391,"roa":"-55.08%","roe":"-168.34%","lyrEps":-2.109975,"volumeRatio":1.037946,"shares":26585258,"dividePrice":0,"high":1.89,"amplitude":0.054945,"preClose":1.82,"low":1.79,"week52Low":1.71,"pbRate":"1.68","psRate":"967.70","week52High":11.64,"institutionHeld":0,"latestPrice":1.82,"eps":-2.516157,"divideRate":0,"volume":321482,"delay":0,"ttmEps":-2.516157,"open":1.83,"prevYearClose":4.67,"prevWeekClose":1.9,"prevMonthClose":2.07,"prevQuarterClose":2.07,"fiveDayClose":1.78,"twentyDayClose":2.13,"sixtyDayClose":2.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INMB\",params:#limit:5,,,undefined,":[{"date":"2025-10-30","symbol":"INMB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":-0.31,"defaultRemindTime":1761854400000,"name":null,"time":"Post Market","dateTimestamp":1761796800000,"actualEps":null},{"market":"US","date":"2025-08-07","symbol":"INMB","fiscalQuarterEnding":"2025/06","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2025-05-08","symbol":"INMB","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-03-27","symbol":"INMB","fiscalQuarterEnding":"2024/12","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-10-31","symbol":"INMB","fiscalQuarterEnding":"2024/09","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1754971200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INMB","date":"2025-10-28","current":-0.723325,"percent":0.995126,"low":-32.201048,"twenty":-10.426663,"median":-5.040897,"eighty":-3.834394,"high":-0.842943,"avg":-7.40624,"sd":5.793194,"marketCap":48916874},"quantilePoints":[{"date":"2020-10-30","current":-10.77165,"twenty":-11.359846,"median":-8.274932,"eighty":-6.91407,"marketCap":103011281},{"date":"2020-11-06","current":-9.222572,"twenty":-11.376325,"median":-8.30528,"eighty":-6.91407,"marketCap":103414720},{"date":"2020-11-13","current":-10.445852,"twenty":-11.359846,"median":-8.33307,"eighty":-6.928266,"marketCap":117131627},{"date":"2020-11-20","current":-10.709697,"twenty":-11.341007,"median":-8.347696,"eighty":-6.977592,"marketCap":120090175},{"date":"2020-11-27","current":-10.685711,"twenty":-11.325937,"median":-8.38068,"eighty":-6.98292,"marketCap":119821216},{"date":"2020-12-04","current":-10.841619,"twenty":-11.310413,"median":-8.411722,"eighty":-6.984838,"marketCap":121569449},{"date":"2020-12-11","current":-11.069485,"twenty":-11.304159,"median":-8.423524,"eighty":-6.990726,"marketCap":124124560},{"date":"2020-12-18","current":-12.256786,"twenty":-11.310413,"median":-8.436976,"eighty":-6.992162,"marketCap":137438028},{"date":"2020-12-24","current":-15.291,"twenty":-11.366438,"median":-8.4405,"eighty":-6.998492,"marketCap":171461337},{"date":"2020-12-31","current":-20.651845,"twenty":-11.438198,"median":-8.450102,"eighty":-7.006258,"marketCap":231573664},{"date":"2021-01-08","current":-21.899111,"twenty":-11.503022,"median":-8.476686,"eighty":-7.011844,"marketCap":245559530},{"date":"2021-01-15","current":-29.766481,"twenty":-11.621007,"median":-8.488485,"eighty":-7.014672,"marketCap":333778069},{"date":"2021-01-22","current":-24.849375,"twenty":-11.732063,"median":-8.5084,"eighty":-7.019802,"marketCap":278641482},{"date":"2021-01-29","current":-21.887118,"twenty":-11.932549,"median":-8.517311,"eighty":-7.028655,"marketCap":245425051},{"date":"2021-02-05","current":-24.045848,"twenty":-12.228073,"median":-8.535184,"eighty":-7.041597,"marketCap":269631357},{"date":"2021-02-12","current":-23.97389,"twenty":-12.450217,"median":-8.58252,"eighty":-7.047033,"marketCap":268824480},{"date":"2021-02-19","current":-23.086412,"twenty":-12.81067,"median":-8.603835,"eighty":-7.047033,"marketCap":258872999},{"date":"2021-02-26","current":-19.452551,"twenty":-12.93723,"median":-8.628625,"eighty":-7.055897,"marketCap":218125716},{"date":"2021-03-05","current":-17.661464,"twenty":-13.288785,"median":-8.691424,"eighty":-7.061232,"marketCap":213686049},{"date":"2021-03-12","current":-19.648533,"twenty":-13.485656,"median":-8.735449,"eighty":-7.066547,"marketCap":237727596},{"date":"2021-03-19","current":-17.192466,"twenty":-13.837211,"median":-8.763426,"eighty":-7.068231,"marketCap":208011647},{"date":"2021-03-26","current":-15.291791,"twenty":-14.132517,"median":-8.797758,"eighty":-7.073626,"marketCap":185015384},{"date":"2021-04-01","current":-15.205397,"twenty":-14.405324,"median":-8.816597,"eighty":-7.079116,"marketCap":183970100},{"date":"2021-04-09","current":-14.526585,"twenty":-14.448952,"median":-8.86892,"eighty":-7.081879,"marketCap":175757149},{"date":"2021-04-16","current":-16.809863,"twenty":-14.481401,"median":-8.928017,"eighty":-7.082437,"marketCap":203382529},{"date":"2021-04-23","current":-14.748742,"twenty":-14.503825,"median":-8.985555,"eighty":-7.083384,"marketCap":178445024},{"date":"2021-04-30","current":-14.650005,"twenty":-14.557196,"median":-9.023825,"eighty":-7.086259,"marketCap":177250413},{"date":"2021-05-07","current":-10.944799,"twenty":-14.557196,"median":-9.09522,"eighty":-7.090468,"marketCap":159629900},{"date":"2021-05-14","current":-10.013109,"twenty":-14.532145,"median":-9.153781,"eighty":-7.091354,"marketCap":146041199},{"date":"2021-05-21","current":-14.272264,"twenty":-14.526585,"median":-9.169564,"eighty":-7.095026,"marketCap":208160973},{"date":"2021-05-28","current":-13.883207,"twenty":-14.506838,"median":-9.201475,"eighty":-7.10099,"marketCap":202486571},{"date":"2021-06-04","current":-13.688678,"twenty":-14.499641,"median":-9.222572,"eighty":-7.107607,"marketCap":199649370},{"date":"2021-06-11","current":-18.316414,"twenty":-14.560008,"median":-9.240497,"eighty":-7.112159,"marketCap":267144893},{"date":"2021-06-18","current":-18.10665,"twenty":-14.643256,"median":-9.258353,"eighty":-7.115581,"marketCap":264085485},{"date":"2021-06-25","current":-19.765907,"twenty":-14.664161,"median":-9.283837,"eighty":-7.124538,"marketCap":288285759},{"date":"2021-07-02","current":-18.39702,"twenty":-14.70431,"median":-9.302101,"eighty":-7.1541,"marketCap":268320533},{"date":"2021-07-09","current":-23.820718,"twenty":-14.750249,"median":-9.306408,"eighty":-7.170663,"marketCap":347425177},{"date":"2021-07-16","current":-25.5709,"twenty":-14.907866,"median":-9.347633,"eighty":-7.176186,"marketCap":372951575},{"date":"2021-07-23","current":-25.498255,"twenty":-15.115802,"median":-9.410754,"eighty":-7.184438,"marketCap":371892053},{"date":"2021-07-30","current":-18.427514,"twenty":-15.291475,"median":-9.475958,"eighty":-7.189362,"marketCap":268765292},{"date":"2021-08-06","current":-14.648204,"twenty":-15.291791,"median":-9.552978,"eighty":-7.204176,"marketCap":280249444},{"date":"2021-08-13","current":-15.342213,"twenty":-15.322044,"median":-9.602724,"eighty":-7.215371,"marketCap":293527213},{"date":"2021-08-20","current":-15.295945,"twenty":-15.33481,"median":-9.643151,"eighty":-7.224311,"marketCap":292642028},{"date":"2021-08-27","current":-18.534651,"twenty":-15.542604,"median":-9.67797,"eighty":-7.238398,"marketCap":354604950},{"date":"2021-09-03","current":-24.456857,"twenty":-15.700377,"median":-9.834212,"eighty":-7.241786,"marketCap":467908579},{"date":"2021-09-10","current":-19.956733,"twenty":-16.049173,"median":-10.013109,"eighty":-7.246093,"marketCap":381812208},{"date":"2021-09-17","current":-17.103106,"twenty":-16.294969,"median":-10.096999,"eighty":-7.253876,"marketCap":327216631},{"date":"2021-09-24","current":-18.78171,"twenty":-16.570102,"median":-10.158021,"eighty":-7.269875,"marketCap":359331676},{"date":"2021-10-01","current":-19.005524,"twenty":-16.926763,"median":-10.283748,"eighty":-7.275495,"marketCap":363613682},{"date":"2021-10-08","current":-16.114595,"twenty":-17.07161,"median":-10.299783,"eighty":-7.280483,"marketCap":308304437},{"date":"2021-10-15","current":-17.364223,"twenty":-17.215023,"median":-10.31393,"eighty":-7.292676,"marketCap":332212305},{"date":"2021-10-22","current":-18.61385,"twenty":-17.362358,"median":-10.361386,"eighty":-7.307494,"marketCap":356120172},{"date":"2021-10-29","current":-17.149734,"twenty":-17.438827,"median":-10.450716,"eighty":-7.322192,"marketCap":328108715},{"date":"2021-11-05","current":-10.66577,"twenty":-17.500376,"median":-10.469838,"eighty":-7.334332,"marketCap":254623933},{"date":"2021-11-12","current":-10.852627,"twenty":-17.438827,"median":-10.547639,"eighty":-7.334332,"marketCap":259084759},{"date":"2021-11-19","current":-9.993087,"twenty":-17.396814,"median":-10.493258,"eighty":-7.336898,"marketCap":238564961},{"date":"2021-11-26","current":-9.96319,"twenty":-17.377971,"median":-10.463597,"eighty":-7.347164,"marketCap":237851228},{"date":"2021-12-03","current":-8.386121,"twenty":-17.364223,"median":-10.413038,"eighty":-7.363704,"marketCap":200201859},{"date":"2021-12-10","current":-9.021433,"twenty":-17.354897,"median":-10.349909,"eighty":-7.364085,"marketCap":215368667},{"date":"2021-12-17","current":-8.072202,"twenty":-17.289618,"median":-10.31393,"eighty":-7.391283,"marketCap":192707672},{"date":"2021-12-23","current":-8.117047,"twenty":-17.234453,"median":-10.294863,"eighty":-7.411299,"marketCap":193778270},{"date":"2021-12-31","current":-7.623746,"twenty":-17.198105,"median":-10.277951,"eighty":-7.420777,"marketCap":182001690},{"date":"2022-01-07","current":-6.71936,"twenty":-17.188123,"median":-10.250588,"eighty":-7.385843,"marketCap":160411293},{"date":"2022-01-14","current":-6.562401,"twenty":-17.157195,"median":-10.158021,"eighty":-7.334332,"marketCap":156664200},{"date":"2022-01-21","current":-6.562401,"twenty":-17.121757,"median":-10.134036,"eighty":-7.313325,"marketCap":156664200},{"date":"2022-01-28","current":-6.637144,"twenty":-17.052748,"median":-10.0209,"eighty":-7.27235,"marketCap":158448530},{"date":"2022-02-04","current":-7.743334,"twenty":-16.975045,"median":-9.978127,"eighty":-7.267176,"marketCap":184856619},{"date":"2022-02-11","current":-7.945139,"twenty":-16.88904,"median":-9.880015,"eighty":-7.27235,"marketCap":189674310},{"date":"2022-02-18","current":-7.362147,"twenty":-16.851316,"median":-9.695826,"eighty":-7.276836,"marketCap":175756534},{"date":"2022-02-25","current":-6.995908,"twenty":-16.834735,"median":-9.652795,"eighty":-7.266444,"marketCap":167013316},{"date":"2022-03-04","current":-4.58647,"twenty":-16.800333,"median":-9.60783,"eighty":-7.241786,"marketCap":139153510},{"date":"2022-03-11","current":-3.779864,"twenty":-16.748358,"median":-9.597618,"eighty":-7.215371,"marketCap":114681069},{"date":"2022-03-18","current":-4.798425,"twenty":-16.669835,"median":-9.532204,"eighty":-7.176186,"marketCap":145584224},{"date":"2022-03-25","current":-5.295931,"twenty":-16.622116,"median":-9.475958,"eighty":-7.114659,"marketCap":160678539},{"date":"2022-04-01","current":-4.927953,"twenty":-16.540155,"median":-9.391739,"eighty":-7.09319,"marketCap":149514105},{"date":"2022-04-08","current":-4.557032,"twenty":-16.41045,"median":-9.356561,"eighty":-7.082937,"marketCap":138260355},{"date":"2022-04-14","current":-4.892628,"twenty":-16.340139,"median":-9.338705,"eighty":-7.074998,"marketCap":148442319},{"date":"2022-04-22","current":-4.051749,"twenty":-16.294969,"median":-9.313406,"eighty":-7.056964,"marketCap":122930065},{"date":"2022-04-29","current":-4.448051,"twenty":-16.264517,"median":-9.302101,"eighty":-7.028655,"marketCap":134953882},{"date":"2022-05-06","current":-4.123181,"twenty":-16.177128,"median":-9.283837,"eighty":-7.011001,"marketCap":134774422},{"date":"2022-05-13","current":-3.89259,"twenty":-16.108012,"median":-9.268083,"eighty":-6.992162,"marketCap":127237104},{"date":"2022-05-20","current":-4.035337,"twenty":-16.076093,"median":-9.252521,"eighty":-6.938131,"marketCap":131903063},{"date":"2022-05-27","current":-3.733373,"twenty":-16.049173,"median":-9.240497,"eighty":-6.904704,"marketCap":122032766},{"date":"2022-06-03","current":-3.810237,"twenty":-16.030915,"median":-9.222572,"eighty":-6.883794,"marketCap":124545205},{"date":"2022-06-10","current":-4.128671,"twenty":-16.030665,"median":-9.198666,"eighty":-6.853897,"marketCap":134953882},{"date":"2022-06-17","current":-3.8871,"twenty":-15.988728,"median":-9.169073,"eighty":-6.816526,"marketCap":127057644},{"date":"2022-06-24","current":-4.485538,"twenty":-15.776756,"median":-9.153781,"eighty":-6.781965,"marketCap":146618779},{"date":"2022-07-01","current":-4.814953,"twenty":-15.676991,"median":-9.09522,"eighty":-6.723374,"marketCap":157386376},{"date":"2022-07-08","current":-5.60555,"twenty":-15.638009,"median":-9.045047,"eighty":-6.718318,"marketCap":183228608},{"date":"2022-07-15","current":-5.622021,"twenty":-15.604919,"median":-9.019989,"eighty":-6.69376,"marketCap":183766988},{"date":"2022-07-22","current":-5.122407,"twenty":-15.593228,"median":-8.985555,"eighty":-6.666807,"marketCap":167436133},{"date":"2022-07-29","current":-4.924758,"twenty":-15.517879,"median":-8.928017,"eighty":-6.648259,"marketCap":160975575},{"date":"2022-08-05","current":-5.672616,"twenty":-15.443115,"median":-8.900085,"eighty":-6.630424,"marketCap":186458888},{"date":"2022-08-12","current":-5.137567,"twenty":-15.378871,"median":-8.829808,"eighty":-6.614721,"marketCap":168871812},{"date":"2022-08-19","current":-4.782687,"twenty":-15.344244,"median":-8.813572,"eighty":-6.562401,"marketCap":157206916},{"date":"2022-08-26","current":-4.54792,"twenty":-15.331109,"median":-8.794096,"eighty":-6.517939,"marketCap":149490138},{"date":"2022-09-02","current":-4.449646,"twenty":-15.307049,"median":-8.747284,"eighty":-6.410235,"marketCap":146259859},{"date":"2022-09-09","current":-4.515162,"twenty":-15.294283,"median":-8.720132,"eighty":-6.30054,"marketCap":148413378},{"date":"2022-09-16","current":-4.280395,"twenty":-15.291791,"median":-8.678032,"eighty":-6.169279,"marketCap":140696600},{"date":"2022-09-23","current":-3.772645,"twenty":-15.291475,"median":-8.619446,"eighty":-6.093555,"marketCap":124006825},{"date":"2022-09-30","current":-3.385007,"twenty":-15.276609,"median":-8.59768,"eighty":-6.018493,"marketCap":111265169},{"date":"2022-10-07","current":-3.587015,"twenty":-15.235172,"median":-8.571362,"eighty":-5.981814,"marketCap":117905187},{"date":"2022-10-14","current":-3.385007,"twenty":-15.195523,"median":-8.53371,"eighty":-5.928611,"marketCap":111265169},{"date":"2022-10-21","current":-4.040169,"twenty":-15.115802,"median":-8.511397,"eighty":-5.824533,"marketCap":132800363},{"date":"2022-10-28","current":-4.264016,"twenty":-15.007186,"median":-8.5084,"eighty":-5.653431,"marketCap":140158220},{"date":"2022-11-04","current":-4.484049,"twenty":-14.984687,"median":-8.485886,"eighty":-5.582491,"marketCap":139619841},{"date":"2022-11-11","current":-4.32267,"twenty":-14.965,"median":-8.479856,"eighty":-5.545911,"marketCap":134594962},{"date":"2022-11-18","current":-4.224689,"twenty":-14.935497,"median":-8.461395,"eighty":-5.484764,"marketCap":131544143},{"date":"2022-11-25","current":-4.069073,"twenty":-14.902739,"median":-8.443693,"eighty":-5.34109,"marketCap":126698724},{"date":"2022-12-02","current":-3.984464,"twenty":-14.831046,"median":-8.436976,"eighty":-5.213846,"marketCap":124064252},{"date":"2022-12-09","current":-4.443704,"twenty":-14.765317,"median":-8.423524,"eighty":-5.122277,"marketCap":138363621},{"date":"2022-12-16","current":-4.305379,"twenty":-14.762504,"median":-8.411722,"eighty":-5.080786,"marketCap":134056582},{"date":"2022-12-23","current":-4.051782,"twenty":-14.751002,"median":-8.385906,"eighty":-5.017829,"marketCap":126160344},{"date":"2022-12-30","current":-3.654097,"twenty":-14.749992,"median":-8.37342,"eighty":-4.979236,"marketCap":113777608},{"date":"2023-01-06","current":-4.034492,"twenty":-14.748992,"median":-8.347696,"eighty":-4.957396,"marketCap":125621965},{"date":"2023-01-13","current":-5.094987,"twenty":-14.748742,"median":-8.333801,"eighty":-4.927314,"marketCap":158642595},{"date":"2023-01-20","current":-4.507103,"twenty":-14.726526,"median":-8.331087,"eighty":-4.92471,"marketCap":140337680},{"date":"2023-01-27","current":-4.812572,"twenty":-14.70431,"median":-8.293589,"eighty":-4.863379,"marketCap":149849058},{"date":"2023-02-03","current":-4.956661,"twenty":-14.698159,"median":-8.273824,"eighty":-4.863379,"marketCap":154335557},{"date":"2023-02-10","current":-5.463854,"twenty":-14.690071,"median":-8.2591,"eighty":-4.883594,"marketCap":170128032},{"date":"2023-02-17","current":-5.671342,"twenty":-14.682653,"median":-8.256702,"eighty":-4.898729,"marketCap":176588590},{"date":"2023-02-24","current":-5.175676,"twenty":-14.675318,"median":-8.231631,"eighty":-4.911534,"marketCap":161155035},{"date":"2023-03-03","current":-5.752132,"twenty":-14.665067,"median":-8.219205,"eighty":-4.924687,"marketCap":157027456},{"date":"2023-03-10","current":-4.542541,"twenty":-14.662347,"median":-8.214213,"eighty":-4.911534,"marketCap":124006825},{"date":"2023-03-17","current":-4.325603,"twenty":-14.65741,"median":-8.196054,"eighty":-4.860048,"marketCap":118084647},{"date":"2023-03-24","current":-4.312456,"twenty":-14.650005,"median":-8.176841,"eighty":-4.829288,"marketCap":117725727},{"date":"2023-03-31","current":-4.246717,"twenty":-14.649285,"median":-8.139447,"eighty":-4.788982,"marketCap":115931127},{"date":"2023-04-06","current":-4.273012,"twenty":-14.646315,"median":-8.119592,"eighty":-4.766844,"marketCap":116648967},{"date":"2023-04-14","current":-5.686393,"twenty":-14.635094,"median":-8.112902,"eighty":-4.766844,"marketCap":155232856},{"date":"2023-04-21","current":-5.226223,"twenty":-14.618482,"median":-8.069415,"eighty":-4.770788,"marketCap":142670660},{"date":"2023-04-28","current":-4.503098,"twenty":-14.607952,"median":-8.01182,"eighty":-4.761822,"marketCap":122930065},{"date":"2023-05-05","current":-5.037566,"twenty":-14.597099,"median":-7.994008,"eighty":-4.76177,"marketCap":135671722},{"date":"2023-05-12","current":-5.550651,"twenty":-14.590945,"median":-7.985903,"eighty":-4.766103,"marketCap":149490138},{"date":"2023-05-19","current":-4.784355,"twenty":-14.565891,"median":-7.963363,"eighty":-4.766844,"marketCap":128852244},{"date":"2023-05-26","current":-4.744374,"twenty":-14.555413,"median":-7.950009,"eighty":-4.766844,"marketCap":127775484},{"date":"2023-06-02","current":-5.224142,"twenty":-14.554383,"median":-7.945139,"eighty":-4.768987,"marketCap":140696600},{"date":"2023-06-09","current":-5.597295,"twenty":-14.526585,"median":-7.899933,"eighty":-4.777991,"marketCap":150746358},{"date":"2023-06-16","current":-6.143698,"twenty":-14.526585,"median":-7.877871,"eighty":-4.782687,"marketCap":165462073},{"date":"2023-06-23","current":-6.05041,"twenty":-14.506838,"median":-7.862922,"eighty":-4.784021,"marketCap":162949634},{"date":"2023-06-30","current":-5.670593,"twenty":-14.499641,"median":-7.852366,"eighty":-4.792797,"marketCap":152720417},{"date":"2023-07-07","current":-5.803862,"twenty":-14.498135,"median":-7.810603,"eighty":-4.804084,"marketCap":156309616},{"date":"2023-07-14","current":-6.563495,"twenty":-14.489768,"median":-7.793419,"eighty":-4.813524,"marketCap":176768050},{"date":"2023-07-21","current":-5.970448,"twenty":-14.463085,"median":-7.748803,"eighty":-4.820117,"marketCap":160796115},{"date":"2023-07-28","current":-5.570642,"twenty":-14.436261,"median":-7.738829,"eighty":-4.829118,"marketCap":150028518},{"date":"2023-08-04","current":-5.743891,"twenty":-14.416574,"median":-7.728386,"eighty":-4.831169,"marketCap":154694476},{"date":"2023-08-11","current":-5.692131,"twenty":-14.371464,"median":-7.688821,"eighty":-4.831571,"marketCap":151382212},{"date":"2023-08-18","current":-4.295344,"twenty":-14.323598,"median":-7.661117,"eighty":-4.831169,"marketCap":114234680},{"date":"2023-08-25","current":-4.491863,"twenty":-14.298101,"median":-7.639701,"eighty":-4.804084,"marketCap":119461104},{"date":"2023-09-01","current":-4.548012,"twenty":-14.216365,"median":-7.623746,"eighty":-4.772589,"marketCap":120954367},{"date":"2023-09-08","current":-5.387195,"twenty":-14.117531,"median":-7.614167,"eighty":-4.766103,"marketCap":143272451},{"date":"2023-09-15","current":-5.583709,"twenty":-14.05265,"median":-7.577863,"eighty":-4.766844,"marketCap":148498742},{"date":"2023-09-22","current":-4.811206,"twenty":-14.02856,"median":-7.55676,"eighty":-4.766844,"marketCap":127954013},{"date":"2023-09-29","current":-4.750218,"twenty":-14.001703,"median":-7.552768,"eighty":-4.752314,"marketCap":126332060},{"date":"2023-10-06","current":-4.621468,"twenty":-13.959944,"median":-7.535451,"eighty":-4.743442,"marketCap":122907939},{"date":"2023-10-13","current":-4.817982,"twenty":-13.937214,"median":-7.514461,"eighty":-4.729837,"marketCap":128134230},{"date":"2023-10-20","current":-5.06193,"twenty":-13.902659,"median":-7.512855,"eighty":-4.728197,"marketCap":134622039},{"date":"2023-10-27","current":-4.729889,"twenty":-13.892933,"median":-7.487811,"eighty":-4.729043,"marketCap":125791410},{"date":"2023-11-03","current":-4.467157,"twenty":-13.880922,"median":-7.456035,"eighty":-4.715928,"marketCap":122547505},{"date":"2023-11-10","current":-4.565697,"twenty":-13.860422,"median":-7.432279,"eighty":-4.714445,"marketCap":125250759},{"date":"2023-11-17","current":-4.63796,"twenty":-13.841435,"median":-7.419099,"eighty":-4.7061,"marketCap":127233145},{"date":"2023-11-24","current":-6.116063,"twenty":-13.836499,"median":-7.377684,"eighty":-4.70881,"marketCap":167781952},{"date":"2023-12-01","current":-6.208034,"twenty":-13.834818,"median":-7.362147,"eighty":-4.711426,"marketCap":170304989},{"date":"2023-12-08","current":-6.667888,"twenty":-13.8296,"median":-7.334332,"eighty":-4.714372,"marketCap":182920173},{"date":"2023-12-15","current":-7.383947,"twenty":-13.798441,"median":-7.334332,"eighty":-4.715483,"marketCap":202563818},{"date":"2023-12-22","current":-6.766428,"twenty":-13.757962,"median":-7.311867,"eighty":-4.720539,"marketCap":185623427},{"date":"2023-12-29","current":-7.521903,"twenty":-13.752838,"median":-7.304578,"eighty":-4.726119,"marketCap":206348373},{"date":"2024-01-05","current":-7.942342,"twenty":-13.714342,"median":-7.32199,"eighty":-4.727112,"marketCap":217882256},{"date":"2024-01-12","current":-7.607305,"twenty":-13.688678,"median":-7.334332,"eighty":-4.729043,"marketCap":208691193},{"date":"2024-01-19","current":-7.121173,"twenty":-13.663718,"median":-7.334332,"eighty":-4.729889,"marketCap":195355141},{"date":"2024-01-26","current":-7.7584,"twenty":-13.616139,"median":-7.342563,"eighty":-4.733169,"marketCap":212836182},{"date":"2024-02-02","current":-6.917523,"twenty":-13.586886,"median":-7.362147,"eighty":-4.740082,"marketCap":189768416},{"date":"2024-02-09","current":-7.817524,"twenty":-13.586886,"median":-7.383947,"eighty":-4.740082,"marketCap":214458134},{"date":"2024-02-16","current":-9.052561,"twenty":-13.586886,"median":-7.432279,"eighty":-4.740082,"marketCap":248338915},{"date":"2024-02-23","current":-8.320079,"twenty":-13.586886,"median":-7.45621,"eighty":-4.740082,"marketCap":228244729},{"date":"2024-03-01","current":-7.620444,"twenty":-13.579863,"median":-7.512855,"eighty":-4.741077,"marketCap":209051627},{"date":"2024-03-08","current":-8.211685,"twenty":-13.579863,"median":-7.532316,"eighty":-4.741077,"marketCap":225271150},{"date":"2024-03-15","current":-7.515334,"twenty":-13.579863,"median":-7.555984,"eighty":-4.741077,"marketCap":206168156},{"date":"2024-03-22","current":-7.830663,"twenty":-13.579863,"median":-7.55676,"eighty":-4.741077,"marketCap":214818568},{"date":"2024-03-28","current":-7.640152,"twenty":-13.579863,"median":-7.591653,"eighty":-4.741077,"marketCap":209592277},{"date":"2024-04-05","current":-6.157403,"twenty":-13.586886,"median":-7.598129,"eighty":-4.740082,"marketCap":184771348},{"date":"2024-04-12","current":-6.571901,"twenty":-13.586886,"median":-7.567889,"eighty":-4.740082,"marketCap":197209614},{"date":"2024-04-19","current":-5.286356,"twenty":-13.586886,"median":-7.55549,"eighty":-4.740082,"marketCap":158632962},{"date":"2024-04-26","current":-6.782219,"twenty":-13.579863,"median":-7.525542,"eighty":-4.741077,"marketCap":203520837},{"date":"2024-05-03","current":-7.329371,"twenty":-13.579863,"median":-7.515362,"eighty":-4.741077,"marketCap":219939763},{"date":"2024-05-10","current":-7.092302,"twenty":-13.579863,"median":-7.483373,"eighty":-4.741077,"marketCap":212825808},{"date":"2024-05-17","current":-6.405477,"twenty":-13.579863,"median":-7.442187,"eighty":-4.741077,"marketCap":220969731},{"date":"2024-05-24","current":-5.80335,"twenty":-13.579863,"median":-7.419099,"eighty":-4.741077,"marketCap":200198181},{"date":"2024-05-31","current":-5.46788,"twenty":-13.579863,"median":-7.373138,"eighty":-4.741077,"marketCap":188625460},{"date":"2024-06-07","current":-5.13241,"twenty":-13.579863,"median":-7.354655,"eighty":-4.741077,"marketCap":177052739},{"date":"2024-06-14","current":-5.206959,"twenty":-13.586886,"median":-7.334332,"eighty":-4.740082,"marketCap":179624455},{"date":"2024-06-21","current":-4.415593,"twenty":-13.593908,"median":-7.299729,"eighty":-4.729889,"marketCap":152324703},{"date":"2024-06-28","current":-4.983312,"twenty":-13.61107,"median":-7.278178,"eighty":-4.729043,"marketCap":171909308},{"date":"2024-07-05","current":-4.581894,"twenty":-13.61107,"median":-7.264982,"eighty":-4.722399,"marketCap":158061607},{"date":"2024-07-12","current":-5.184021,"twenty":-13.61107,"median":-7.239596,"eighty":-4.712359,"marketCap":178833158},{"date":"2024-07-15","current":-5.298711,"twenty":-13.61107,"median":-7.239421,"eighty":-4.712359,"marketCap":182789643},{"date":"2024-08-02","current":-4.146018,"twenty":-13.688678,"median":-7.177561,"eighty":-4.698344,"marketCap":156479013},{"date":"2024-08-09","current":-3.97829,"twenty":-13.688678,"median":-7.1193,"eighty":-4.673493,"marketCap":150148636},{"date":"2024-08-16","current":-3.597,"twenty":-13.688678,"median":-7.098705,"eighty":-4.660833,"marketCap":135757966},{"date":"2024-08-23","current":-3.377096,"twenty":-13.688678,"median":-7.081357,"eighty":-4.634575,"marketCap":127458353},{"date":"2024-08-30","current":-3.591764,"twenty":-13.688678,"median":-7.049362,"eighty":-4.618844,"marketCap":135560357},{"date":"2024-09-06","current":-3.141485,"twenty":-13.688678,"median":-7.002701,"eighty":-4.598246,"marketCap":118565910},{"date":"2024-09-13","current":-3.345681,"twenty":-13.688678,"median":-6.952929,"eighty":-4.58647,"marketCap":126272694},{"date":"2024-09-20","current":-3.131237,"twenty":-13.688678,"median":-6.906659,"eighty":-4.580678,"marketCap":118179163},{"date":"2024-09-27","current":-2.903924,"twenty":-13.688678,"median":-6.870645,"eighty":-4.565697,"marketCap":109599899},{"date":"2024-10-04","current":-3.102983,"twenty":-13.688678,"median":-6.81347,"eighty":-4.55338,"marketCap":117112796},{"date":"2024-10-11","current":-2.939052,"twenty":-13.688678,"median":-6.769054,"eighty":-4.542541,"marketCap":110925705},{"date":"2024-10-18","current":-2.927343,"twenty":-13.688678,"median":-6.723897,"eighty":-4.515162,"marketCap":110483770},{"date":"2024-10-25","current":-3.056146,"twenty":-13.688678,"median":-6.695693,"eighty":-4.499873,"marketCap":115345055},{"date":"2024-10-31","current":-3.483538,"twenty":-13.688678,"median":-6.649164,"eighty":-4.491863,"marketCap":131475686},{"date":"2024-11-08","current":-3.341555,"twenty":-13.70151,"median":-6.620238,"eighty":-4.483072,"marketCap":137912645},{"date":"2024-11-15","current":-2.922517,"twenty":-13.70151,"median":-6.577909,"eighty":-4.471791,"marketCap":120618133},{"date":"2024-11-22","current":-2.557203,"twenty":-13.70151,"median":-6.57735,"eighty":-4.449646,"marketCap":105540866},{"date":"2024-11-29","current":-2.712999,"twenty":-13.70151,"median":-6.571901,"eighty":-4.440809,"marketCap":111970877},{"date":"2024-12-06","current":-2.616298,"twenty":-13.70151,"median":-6.517555,"eighty":-4.427747,"marketCap":107979836},{"date":"2024-12-13","current":-2.616298,"twenty":-13.70151,"median":-6.405477,"eighty":-4.410823,"marketCap":107979836},{"date":"2024-12-20","current":-2.374545,"twenty":-13.70151,"median":-6.323611,"eighty":-4.40331,"marketCap":98002233},{"date":"2024-12-27","current":-2.541086,"twenty":-13.70151,"median":-6.286866,"eighty":-4.385676,"marketCap":104875693},{"date":"2025-01-03","current":-2.648531,"twenty":-13.70151,"median":-6.226059,"eighty":-4.338224,"marketCap":109310183},{"date":"2025-01-10","current":-2.847305,"twenty":-13.714342,"median":-6.206881,"eighty":-4.327301,"marketCap":117513990},{"date":"2025-01-17","current":-3.610168,"twenty":-13.714342,"median":-6.170541,"eighty":-4.309625,"marketCap":148998870},{"date":"2025-01-24","current":-4.233352,"twenty":-13.714342,"median":-6.147785,"eighty":-4.281536,"marketCap":174718913},{"date":"2025-01-31","current":-4.953237,"twenty":-13.714342,"median":-6.116063,"eighty":-4.280362,"marketCap":204429998},{"date":"2025-02-07","current":-5.264829,"twenty":-13.714342,"median":-6.068848,"eighty":-4.280362,"marketCap":217290019},{"date":"2025-02-14","current":-4.996215,"twenty":-13.714342,"median":-6.034452,"eighty":-4.280362,"marketCap":206203794},{"date":"2025-02-21","current":-4.883397,"twenty":-13.714342,"median":-6.010371,"eighty":-4.280362,"marketCap":201547579},{"date":"2025-02-28","current":-4.217235,"twenty":-13.714342,"median":-5.973476,"eighty":-4.272126,"marketCap":174053740},{"date":"2025-03-07","current":-4.308564,"twenty":-13.727174,"median":-5.962507,"eighty":-4.268681,"marketCap":177823057},{"date":"2025-03-14","current":-4.319309,"twenty":-13.727174,"median":-5.943795,"eighty":-4.268681,"marketCap":178266506},{"date":"2025-03-21","current":-4.373031,"twenty":-13.727174,"median":-5.943795,"eighty":-4.27178,"marketCap":180483751},{"date":"2025-03-28","current":-4.037679,"twenty":-13.727174,"median":-5.943795,"eighty":-4.280346,"marketCap":169913604},{"date":"2025-04-04","current":-4.233841,"twenty":-13.727174,"median":-5.943795,"eighty":-4.27178,"marketCap":178168516},{"date":"2025-04-11","current":-3.66715,"twenty":-13.714342,"median":-5.939937,"eighty":-4.261832,"marketCap":154320993},{"date":"2025-04-17","current":-3.983189,"twenty":-13.714342,"median":-5.898886,"eighty":-4.246717,"marketCap":167620573},{"date":"2025-04-25","current":-4.380963,"twenty":-13.727174,"median":-5.797616,"eighty":-4.237709,"marketCap":184359700},{"date":"2025-05-02","current":-4.145464,"twenty":-13.727174,"median":-5.743891,"eighty":-4.236718,"marketCap":174449432},{"date":"2025-05-09","current":-3.872377,"twenty":-13.727174,"median":-5.710574,"eighty":-4.226225,"marketCap":162957375},{"date":"2025-05-16","current":-4.147555,"twenty":-13.727174,"median":-5.68392,"eighty":-4.218916,"marketCap":169203648},{"date":"2025-05-23","current":-4.267032,"twenty":-13.727174,"median":-5.66393,"eighty":-4.218916,"marketCap":174077827},{"date":"2025-05-30","current":-4.18738,"twenty":-13.727174,"median":-5.630144,"eighty":-4.195871,"marketCap":170828374},{"date":"2025-06-06","current":-4.181691,"twenty":-13.727174,"median":-5.60555,"eighty":-4.18746,"marketCap":170596270},{"date":"2025-06-13","current":-4.505986,"twenty":-13.727174,"median":-5.583709,"eighty":-4.18746,"marketCap":183826185},{"date":"2025-06-20","current":-4.119108,"twenty":-13.740006,"median":-5.565548,"eighty":-4.185357,"marketCap":168043129},{"date":"2025-06-27","current":-3.572928,"twenty":-13.740006,"median":-5.548847,"eighty":-4.164748,"marketCap":145761167},{"date":"2025-07-03","current":-1.648708,"twenty":-13.740006,"median":-5.528092,"eighty":-4.155932,"marketCap":67260702},{"date":"2025-07-11","current":-1.453209,"twenty":-13.740006,"median":-5.491798,"eighty":-4.147997,"marketCap":59285125},{"date":"2025-07-18","current":-1.459726,"twenty":-13.593908,"median":-5.471955,"eighty":-4.130089,"marketCap":59550977},{"date":"2025-07-25","current":-1.811624,"twenty":-13.384408,"median":-5.443985,"eighty":-4.120534,"marketCap":73907017},{"date":"2025-08-01","current":-1.779041,"twenty":-13.250549,"median":-5.40707,"eighty":-4.115166,"marketCap":72577754},{"date":"2025-08-08","current":-1.818141,"twenty":-13.072922,"median":-5.38086,"eighty":-4.092052,"marketCap":74172869},{"date":"2025-08-15","current":-1.173414,"twenty":-12.856875,"median":-5.344496,"eighty":-4.074836,"marketCap":65133882},{"date":"2025-08-22","current":-1.12552,"twenty":-12.287556,"median":-5.306639,"eighty":-4.051756,"marketCap":62475356},{"date":"2025-08-29","current":-1.000994,"twenty":-11.707447,"median":-5.267434,"eighty":-4.035805,"marketCap":55563189},{"date":"2025-09-05","current":-0.919574,"twenty":-11.57763,"median":-5.24334,"eighty":-4.011437,"marketCap":51043695},{"date":"2025-09-12","current":-0.943521,"twenty":-11.398824,"median":-5.220964,"eighty":-3.983444,"marketCap":52372958},{"date":"2025-09-19","current":-0.943521,"twenty":-11.205601,"median":-5.193589,"eighty":-3.970934,"marketCap":52372958},{"date":"2025-09-26","current":-0.972258,"twenty":-10.982131,"median":-5.146132,"eighty":-3.961591,"marketCap":53968073},{"date":"2025-10-03","current":-1.024941,"twenty":-10.876545,"median":-5.116358,"eighty":-3.939387,"marketCap":56892452},{"date":"2025-10-10","current":-0.94831,"twenty":-10.757669,"median":-5.094423,"eighty":-3.903264,"marketCap":52638810},{"date":"2025-10-17","current":-0.886048,"twenty":-10.662562,"median":-5.062692,"eighty":-3.87591,"marketCap":49182727},{"date":"2025-10-24","current":-0.857311,"twenty":-10.46859,"median":-5.049811,"eighty":-3.85516,"marketCap":47587611},{"date":"2025-10-28","current":-0.881258,"twenty":-10.426663,"median":-5.040897,"eighty":-3.834394,"marketCap":48916874}],"updateTime":1761798569459},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INMB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556061382","title":"BUZZ-INmune Bio rises as prostate cancer therapy meets trial goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2556061382","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556061382?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:45","pubTimestamp":1754315112,"startTime":"0","endTime":"0","summary":"BUZZ-INmune Bio rises as prostate cancer therapy meets trial goals** Shares of drug developer INmune Bio INMB.O rise 7% to $2.74 in early trade** Co says its therapy for a type of prostate cancer has met the main and secondary goals of an early-to-mid-stage study** INMB says the therapy, INKmune, \"was well tolerated at all three dose levels in the trial, demonstrating an excellent safety profile,\" which was the main goal of the trial** As a result, co stops further enrollment into the study** Including session's moves, stock down 41.3% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL6N3TW0KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2556894793","title":"INmune Bio Announces Successful Completion of Phase I/II Trial for INKmune™ in Metastatic Castration-Resistant Prostate Cancer, Plans Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2556894793","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556894793?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:01","pubTimestamp":1754308877,"startTime":"0","endTime":"0","summary":"INmune Bio Announces Successful Completion of Phase I/II Trial for INKmune in Metastatic Castration-Resistant Prostate Cancer, Plans Phase 2b Trial. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on August 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL5STN5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","LU2210149790.SGD","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4139","IE00BKPKM429.USD","NDAQ","BK4585","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4112","LU2095319765.USD"],"gpt_icon":0},{"id":"2556899333","title":"INmune Bio’s Care PC Trial of Inkmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2556899333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556899333?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:00","pubTimestamp":1754308800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA1HYMKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INMB"],"gpt_icon":0},{"id":"2556478389","title":"INmune Bio Inc - Inkmune Well Tolerated With Excellent Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2556478389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556478389?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:00","pubTimestamp":1754308800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA1HYMKG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2556389266","title":"INmune Bio Inc - Plans Phase 2B Trial for Less Severe Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2556389266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556389266?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:00","pubTimestamp":1754308800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA1HYMKG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INMB","BK4139"],"gpt_icon":0},{"id":"2555295884","title":"INmune Bio Inc. to Report Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2555295884","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555295884?lang=en_us&edition=fundamental","pubTime":"2025-07-31 19:00","pubTimestamp":1753959609,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. will report its second quarter 2025 financial results on August 7, 2025. A conference call to discuss the results will be held on the same day at 4:30 pm ET. Access the live audio webcast of the call by clicking here. Management will host the conference call.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on July 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL4qjTrd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","INMB","BK4112","LU2210150020.SGD","BK4585","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00B64PRP62.GBP","BK4588","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2555058156","title":"INmune Bio Inc. Unveils Promising MINDFuL Trial Results for Alzheimer's Treatment XPro™ at AAIC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555058156","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555058156?lang=en_us&edition=fundamental","pubTime":"2025-07-29 19:01","pubTimestamp":1753786890,"startTime":"0","endTime":"0","summary":"INmune Bio Inc.  has announced the upcoming release of a video detailing additional findings from the Phase 2 MINDFuL trial evaluating XPro, a novel selective soluble TNF inhibitor. This video will be available on the company's YouTube Channel following the conclusion of the Alzheimer's Association International Conference  in Toronto, Canada. The video presentation will provide a comprehensive overview of the clinical insights shared during AAIC, focusing on the evaluation of XPro within the MINDFuL study design and its significance for early-stage Alzheimer's disease therapies. The presentation at AAIC is scheduled for July 29, 2025, from 2:00 to 3:30 PM ET, with the video being made available at 4 PM ET on July 31, 2025. The MINDFuL trial is a double-blind, Phase 2 proof-of-concept study that has demonstrated consistent benefits in slowing cognitive decline in a subpopulation of patients with early-stage Alzheimer's disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDLk25dL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","INMB","IE00BKPKM429.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2554798867","title":"INmune Bio Inc  expected to post a loss of 38 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2554798867","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554798867?lang=en_us&edition=fundamental","pubTime":"2025-07-28 19:45","pubTimestamp":1753703105,"startTime":"0","endTime":"0","summary":"INmune Bio Inc  expected to post a loss of38cents a share - Earnings Preview INmune Bio Inc INMB.OQ INMB.O is expected to  show a rise in quarterly revenue when it reports  results on July 30 (estimat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nL8N3TP0UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":0},{"id":"2553032788","title":"INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2553032788","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553032788?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354800,"startTime":"0","endTime":"0","summary":"Boca Raton, July  24, 2025  (GLOBE NEWSWIRE) --  INmune Bio Inc. (NASDAQ: INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro, a novel selective soluble TNF i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/24/3120917/0/en/INmune-Bio-to-Present-Phase-2-MINDFuL-Trial-Findings-of-XPro-at-the-Alzheimer-s-Association-International-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1216","BK4110","INMB","BK4139","01821","AAIC","LU0149534421.HKD","LU0607220059.USD"],"gpt_icon":0},{"id":"2548819973","title":"INmune Bio Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2548819973","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548819973?lang=en_us&edition=fundamental","pubTime":"2025-07-03 00:09","pubTimestamp":1751472540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INMB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 02, 2025 12:09 ET (16:09 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f89b4939b9a0592f6090f58a4ee5409a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":0},{"id":"2548816258","title":"INmune Bio Shares Fall After Downgrade From BTIG Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2548816258","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548816258?lang=en_us&edition=fundamental","pubTime":"2025-07-02 02:11","pubTimestamp":1751393514,"startTime":"0","endTime":"0","summary":"INmune Bio (INMB) shares fell 7.4% in recent Tuesday trading after BTIG Research downgraded the stock to neutral from buy.Trading volume stood at over 7.5 million shares compared with a daily average of about 2 million.Price: 2.14, Change: -0.17, Percent Change: -7.36","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INMB"],"gpt_icon":0},{"id":"2548009881","title":"INmune Bio Cut to Sector Underperform From Sector Outperform by Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2548009881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548009881?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:11","pubTimestamp":1751371860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INMB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 01, 2025 08:11 ET (12:11 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":0},{"id":"2548003065","title":"BTIG Research Downgrades INmune Bio to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003065","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003065?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:17","pubTimestamp":1751368626,"startTime":"0","endTime":"0","summary":"INmune Bio (INMB) has an average rating of Hold and mean price target of $13.15, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INMB"],"gpt_icon":0},{"id":"2548074199","title":"BUZZ-Scotiabank double downgrades rating on INmune Bio after Alzheimer's drug failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2548074199","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548074199?lang=en_us&edition=fundamental","pubTime":"2025-07-01 17:19","pubTimestamp":1751361584,"startTime":"0","endTime":"0","summary":"BUZZ-Scotiabank double downgrades rating on INmune Bio afterAlzheimer's drug failure** Shares of drug developer INmune Bio INMB.O fall 6.49% to $2.16 in premarket trading** Scotiabank downgrades stock to 'sector underperform' from 'sector outperform'** Slashes PT to $0.60 from $23; an 89% downside to the stock's last close at $5.33** Brokerage cites failure of lead drug XPro, which targets a protein linked to inflammation, to show any health improvements in a study on patients with Alzheimer's disease** On Monday, co said the experimental drug failed to improve cognitive function in early-stage patients during a mid-stage trial** Co plans to file for FDA breakthrough therapy designation and schedule an End-of-Phase 2 meeting with the health regulator in Q4 2025** Brokerage also added that INmune has a very low chance of getting FDA approval for its drug CORDStrom to treat recessive dystrophic epidermolysis bullosa  a rare skin disease** Average rating of 5 analysts is \"buy\"; median PT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL6N3SY0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB"],"gpt_icon":1},{"id":"2548017081","title":"INmune Bio Inc. Closes $19 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2548017081","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548017081?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:05","pubTimestamp":1751313935,"startTime":"0","endTime":"0","summary":"INmune Bio Inc., a clinical-stage inflammation and immunology company, has successfully closed a registered direct offering for the sale of 3,000,000 shares of its common stock at $6.30 per share. The transaction, which follows Nasdaq rules, raised approximately $19 million in gross proceeds. The company plans to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent for the offering. The offering was conducted under an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL2Yp7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","LU2210149790.SGD","NDAQ","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","INMB","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","BK4112"],"gpt_icon":1},{"id":"2548012162","title":"Raymond James Downgrades INmune Bio to Market Perform From Outperform; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2548012162","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548012162?lang=en_us&edition=fundamental","pubTime":"2025-07-01 03:00","pubTimestamp":1751310055,"startTime":"0","endTime":"0","summary":"Price: 2.20, Change: -3.14, Percent Change: -58.82","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","INMB"],"gpt_icon":0},{"id":"2547096987","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2547096987","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547096987?lang=en_us&edition=fundamental","pubTime":"2025-06-30 19:45","pubTimestamp":1751283917,"startTime":"0","endTime":"0","summary":"INmune Bio  shares were 59% lower pre-bell Monday after the company said that a phase 2 trial of its treatment candidate for Alzheimer's disease failed to meet the primary cognitive endpoint in the intent-to-treat population.Blue Gold  shares were 24% lower, paring Friday's rally.Locafy  stock was down 17%, shaving gains from the previous session.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BGL","LCFY","BK7104","BK4139","INMB","BK4023","BGL.AU"],"gpt_icon":0},{"id":"2547723095","title":"INmune Bio Inc. Seeks Breakthrough Therapy Designation for XPro™ Following Promising Phase 2 Alzheimer's Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2547723095","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547723095?lang=en_us&edition=fundamental","pubTime":"2025-06-30 19:30","pubTimestamp":1751283018,"startTime":"0","endTime":"0","summary":"INmune Bio Inc. has announced plans to file for Breakthrough Therapy Designation with the FDA following the results of their Phase 2 MINDFuL trial evaluating XPro in early Alzheimer's Disease. The trial demonstrated cognitive, behavioral, and biological benefits in a subset of patients with two or more biomarkers of inflammation. Additionally, INmune Bio intends to schedule an End-of-Phase 2 meeting with the FDA in Q4 2025 to chart the course for a pivotal trial aimed at supporting the approval of XPro. The company will also engage with regulatory authorities in the UK, EU, and other regions in parallel. This strategic move marks a significant step forward in the development of XPro for treating early Alzheimer's Disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL7XB6w4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","BK4112","INMB","LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2546728890","title":"INmune Bio Inc. Announces $19 Million Registered Direct Offering with Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2546728890","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546728890?lang=en_us&edition=fundamental","pubTime":"2025-06-28 00:16","pubTimestamp":1751040972,"startTime":"0","endTime":"0","summary":"INmune Bio Inc., a clinical-stage inflammation and immunology company, has announced a registered direct offering, securing approximately $19 million through the sale of 3,000,000 shares of its common stock. Priced at $6.30 per share, the offering is set to close around June 30, 2025, subject to customary closing conditions. The proceeds are intended for working capital and general corporate purposes. A.G.P./Alliance Global Partners is the sole placement agent for this offering, which is being conducted under an effective shelf registration statement filed with the U.S. Securities and Exchange Commission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via G","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL4YVvqx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","IE00BKPKM429.USD","BK4112","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","INMB","LU2210149790.SGD","BK4585","LU2095319765.USD"],"gpt_icon":0},{"id":"1129670088","title":"24H | INmune Bio Soars 70% as It to Present Phase 2 Trial Data; BigBear.ai Jumps 5% After a 20% Rally in Prior Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1129670088","media":"Tiger Newspress","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129670088?lang=en_us&edition=fundamental","pubTime":"2025-06-27 09:48","pubTimestamp":1750988925,"startTime":"0","endTime":"0","summary":"$INmune Bio(INMB)$ shares jumped nearly 70% in overnight trading after the company said it would report top-line data from an Alzheimer's disease drug trial on Monday.The Boca Raton, Fla., company sai","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a486ea388a918518e6d65c5191bc0e0d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INMB","BBAI"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}